USING A SABA INHALER* 3 OR MORE TIMES A WEEK IS AN INDICATOR OF INCREASED ASTHMA ATTACKS[1]

Take the test and learn more!

Are your asthma patients over-reliant on their saba inhaler*?

Learn more

down-arrow-icon

Although SABA provides quick relief of symptoms, over-reliance (e.g. patients use SABA three or more times a week) is associated with increased risk of asthma.[1]


Meanwhile, using three or more canisters per year is associated with two times likelihood of hospitalisation.[2]


Some patients see their blue reliever inhaler as the most important part of their asthma treatment. This short test is designed to assess what your patients think of their SABA inhaler and if they may be relying on it too much. It also provides feedback on why and if they should seek help from a doctor or pharmacist.

Take the short test now and find out more!

down-arrow-icon

YOUR PATIENT’S VIEWS ABOUT THEIR BLUE RELIEVER INHALER*

These are things other people have said about their Blue Reliever Inhaler.

Please click on the button that best represents how much you agree, or disagree with each statement.

There are no right or wrong answers. We are interested in your views.

 

NEXT

The Reliever Reliance Test is adapted from the validated and globally used Beliefs about Medicines Questionnaire[3] (BMQ) and has been developed by leading expert in behavioural medicine, Professor Rob Horne, with colleagues from the International Primary Care Respiratory Group (IPCRG). It was fully funded by AstraZeneca UK Limited. The Asthma Right Care initiative is a global movement led by the IPCRG funded by AstraZeneca globally.

This is not medical advice DO NOT stop or change your asthma medication without consulting your health care professional.


  • 1. Global Initiative for Asthma (GINA). Pocket Guide for asthma management and prevention (for adults and children older than 5 years). 2019. Available from: www.ginasthma.org [last accessed 06.01.20].
  • 2. Schatz M. et al. Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data. J Allergy Clin Immunol 2006;117:995–1000.
  • 3. Horne R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health. 1999; 14(1):1-24.
  • * Contains a short acting β2-sympathomimetic drug (SABA = short acting β2-agonist) and is prescribed to achieve rapid relief from asthma symptoms.